Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shrem Fudim Kelner (SFK) was a prominent Israeli investment and holding group that played a foundational role in the development of the Israeli venture capital and life sciences ecosystem. Founded in 1991, the firm served as a major financier for high-tech and healthcare startups, operating through various arms such as SFK Technologies. The group is notably credited with the inception of the Polaris fund, which eventually evolved into Pitango Venture Capital, one of Israel's largest and most successful venture capital firms. Although the original partnership eventually dissolved and the company underwent significant restructuring and rebranding as Polar Investments, SFK's legacy remains tied to the early growth of the Israeli biotech and medical device industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shrem Fudim Kelner.